Señales en vivo de BMEA | Maximiza tus Ganancias con Getagraph.com

VENDER 117483 min ago

@ $16.91

Emitido: 13 feb 2024 @ 15:46

Retorno: -26.96%

Señal anterior: feb 12 - 12:23

Señal anterior: Comprar

Retorno: -5.11 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	680 666
Volumen promedio	1.03M
Capitalización de mercado	437.20M
EPS	$0 ( 2024-04-02 )
Próxima fecha de ganancias	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.29
ATR14	$0.0250 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Butler Thomas Andrew	Buy	407 502	Stock Option (Right to Buy)
2024-01-17	Erdtmann Rainer M	Buy	135 700	Stock Option (Right to Buy)
2024-01-17	Valle Franco	Buy	145 245	Stock Option (Right to Buy)
2024-01-17	Frias Juan Pablo	Buy	111 090	Stock Option (Right to Buy)
2023-12-29	Erdtmann Rainer M	Sell	3 000	Common Stock

INSIDER POWER
34.13
Last 86 transactions
Buy: 9 688 408 \| Sell: 6 373 693

Volumen Correlación

Largo: 0.07 (neutral)

Corto: -0.77 (moderate negative)

Signal:(35.289) Neutral

Biomea Fusion, Inc. Correlación

10 Correlaciones Más Positivas
PT	0.935
TZPS	0.935
RAM	0.935
SVFAU	0.934
COCO	0.928
NAUT	0.926
MLAI	0.924
CERT	0.924
GAINM	0.923
LMB	0.923

10 Correlaciones Más Negativas
MGI	-0.941
NKLA	-0.937
ILPT	-0.932
FCBC	-0.927
LOAN	-0.925
SPFI	-0.924
ALLK	-0.923
RMRM	-0.922
MNDO	-0.922
NKSH	-0.922

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biomea Fusion, Inc. Correlación - Moneda/Commodity

0.62
( weak )

0.06
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.79
( moderate negative )

Biomea Fusion, Inc. Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-1.26M (0.00 %)
EPS:	$-2.73

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-1.26M (0.00 %)
EPS:	$-2.73

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-3.88

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.500

Financial Reports:

No articles found.

Biomea Fusion, Inc.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Actualizaciones en tiempo real para Biomea Fusion, Inc. [BMEA]

Upcoming Earnings Alert